IL315057A - Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders - Google Patents
Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disordersInfo
- Publication number
- IL315057A IL315057A IL315057A IL31505724A IL315057A IL 315057 A IL315057 A IL 315057A IL 315057 A IL315057 A IL 315057A IL 31505724 A IL31505724 A IL 31505724A IL 315057 A IL315057 A IL 315057A
- Authority
- IL
- Israel
- Prior art keywords
- grpr
- gastrin
- treatment
- related disorders
- vivo imaging
- Prior art date
Links
- 108010073466 Bombesin Receptors Proteins 0.000 title 3
- 102000047481 Gastrin-releasing peptide receptors Human genes 0.000 title 3
- 150000001875 compounds Chemical class 0.000 title 1
- 238000011503 in vivo imaging Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/595—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263323831P | 2022-03-25 | 2022-03-25 | |
| PCT/CA2023/050401 WO2023178449A1 (en) | 2022-03-25 | 2023-03-24 | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL315057A true IL315057A (en) | 2024-10-01 |
Family
ID=88099462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL315057A IL315057A (en) | 2022-03-25 | 2023-03-24 | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12246076B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4499663A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025510161A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250007523A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119213011A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023239751A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3246188A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315057A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023178449A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025054727A1 (en) * | 2023-09-13 | 2025-03-20 | Provincial Health Services Authority | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders |
| WO2026133092A1 (en) * | 2024-12-16 | 2026-06-25 | Novartis Ag | Synthesis of compounds binding grpr |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843903A (en) | 1995-11-27 | 1998-12-01 | The Administrators Of The Tulane Educational Fund | Targeted cytotoxic anthracycline analogs |
| EP2100900A1 (en) | 2008-03-07 | 2009-09-16 | Universitätsspital Basel | Bombesin analog peptide antagonist conjugates |
| EP2198878A1 (en) | 2008-12-18 | 2010-06-23 | University Of Miami | Polypeptide bombesin antagonists |
| KR102190005B1 (ko) | 2012-09-25 | 2020-12-15 | 어드밴스드 액셀러레이터 애플리케이션즈 유에스에이, 인코퍼레이티드. | Grpr-양성 암의 검출, 진단과 치료를 위한 grpr-길항제 |
| AU2019469641B2 (en) | 2018-11-13 | 2025-04-03 | Provincial Health Services Authority | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (GRPR) and treatment of GRPR-related disorders |
| TWI878344B (zh) * | 2019-09-17 | 2025-04-01 | 瑞士商諾華公司 | 放射性標記grpr拮抗劑之方法及其套組 |
-
2023
- 2023-03-24 AU AU2023239751A patent/AU2023239751A1/en active Pending
- 2023-03-24 KR KR1020247035353A patent/KR20250007523A/ko active Pending
- 2023-03-24 EP EP23773418.1A patent/EP4499663A1/en active Pending
- 2023-03-24 CN CN202380029657.8A patent/CN119213011A/zh active Pending
- 2023-03-24 WO PCT/CA2023/050401 patent/WO2023178449A1/en not_active Ceased
- 2023-03-24 IL IL315057A patent/IL315057A/en unknown
- 2023-03-24 JP JP2024556499A patent/JP2025510161A/ja active Pending
- 2023-03-24 CA CA3246188A patent/CA3246188A1/en active Pending
- 2023-11-17 US US18/512,708 patent/US12246076B2/en active Active
-
2025
- 2025-02-03 US US19/043,780 patent/US20250195702A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20250195702A1 (en) | 2025-06-19 |
| CN119213011A (zh) | 2024-12-27 |
| AU2023239751A1 (en) | 2024-09-05 |
| US20240123099A1 (en) | 2024-04-18 |
| US12246076B2 (en) | 2025-03-11 |
| WO2023178449A1 (en) | 2023-09-28 |
| KR20250007523A (ko) | 2025-01-14 |
| EP4499663A1 (en) | 2025-02-05 |
| CA3246188A1 (en) | 2023-09-28 |
| JP2025510161A (ja) | 2025-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2956471T3 (es) | Tratamientos del angioedema hereditario | |
| Baltgalvis et al. | Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice | |
| ES2902404T3 (es) | Métodos para utilizar agonistas de fxr. | |
| CA2643744A1 (en) | Cancer imaging and treatment | |
| CN120225197A (zh) | 药物组合及其用途 | |
| JP2009530413A5 (cg-RX-API-DMAC7.html) | ||
| AR040682A1 (es) | Forma de dosificacion una vez al dia de pramipexol | |
| JP2018519340A5 (cg-RX-API-DMAC7.html) | ||
| RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
| ES2600153T3 (es) | Soluciones antiinflamatorias estables para inyección | |
| Al-Salama et al. | Plecanatide: first global approval | |
| Gozzi et al. | Pharmacological stimulation of NMDA receptors via co-agonist site suppresses fMRI response to phencyclidine in the rat | |
| EA202090139A1 (ru) | Контрастный агент для компьютерной томографии | |
| EP4069700A4 (en) | MACROCYCLES FOR USE IN TREATMENT OF DISEASES | |
| CA3300943A1 (en) | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders | |
| HK40120835A (en) | Radiolabeled compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders | |
| EA201000656A1 (ru) | Аминопроизводные 1,2,4-триазола в качестве модуляторов mglur5 | |
| BR112020022377A2 (pt) | método para o tratamento da dor ou cistite intersticial usando um composto indol | |
| Gozes et al. | Potential clinical applications of vasoactive intestinal peptide: a selected update | |
| HK40052697A (en) | Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders | |
| Paternoster et al. | Pharmacological and structure-activity relationship studies of oleoyl-lysophosphatidylinositol synthetic mimetics | |
| EP4266991A4 (en) | IMPLANTABLE IMAGING DEVICES FOR IN VIVO IMAGING | |
| Barinov et al. | Combination treatment for tunnel neuropathies of the lower extremities | |
| IL326583A (en) | Stable glp-1 analogs for the treatment of human disease and disorders | |
| EP4529435A4 (en) | NON-INVASIVE STABILIZED IMAGING SYSTEM OF MICROVASCULATURE IN THE ORAL MUCOSA |